3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Phase 2
1
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Conditions
Colorectal Neoplasms
3
Stomach Neoplasms
1
Neoplasms
1
NSCLC
1
HER2-positive Colorectal Cancer
1
HER2 IHC3+ Advanced Colorectal Cancer
1
Endometrial Neoplasms
1
Colonic Neoplasms
1
Advanced Malignancies
1
Advanced Colorectal Cancer
1
Interventions
osimertinib
3
Vinorelbine
3
Pemetrexed
3
Cisplatin
3
Carboplatin
3
Gemcitabine
2
Gefitinib
2
Docetaxel
2
CP protocol
2
rezivertinib
1
pembrolizumab
1
aumolertinib
1
Taxes
1
Paclitaxel
1
HMPL-013
1
HM781-36B
1
Erlotinib Hydrochloride
1
Albumin-Bound Paclitaxel
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 3
×
NSCLC
×
HMPL-013
×
Clear all
NCT02691299
2019-02-12
FALUCA
Hutchmed
Phase 3
Completed
527 enrolled